Q2 2020 Matinas BioPharma Holdings Inc Earnings Call Transcript
Welcome to the Matinas BioPharma Second Quarter 2020 Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to Peter Vozzo, Investor Relations representative for Matinas BioPharma. You may begin.
Thank you, Jessie. Good afternoon, everyone, and thank you for joining the Matinas BioPharma Second Quarter 2020 Results Conference Call. Just after the market closed today, we issued a press release with our second quarter 2020 financial results along with business updates. The release is available on the Matinas BioPharma website under the Investors section. Speaking on today's call will be Jerry Jabbour, Chief Executive Officer. We also have Dr. Terri Matkovits, Chief Development Officer, who will be available to answer questions during our Q&A session.
At this time, I would like to remind our listeners that remarks made during this call may state management's intentions, hopes, beliefs, expectations or projections
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
